Modulation of mTORC1 Signaling Pathway by HIV-1

Burkitkan Akbay1,2, Anna Shmakova1,2, Yegor Vassetzky1,2,3

  • 1CNRS UMR 9018, Institut Gustave Roussy, Université Paris-Saclay, 114, rue Édouard Vaillant, 94805 Villejuif, France.

Cells
|May 2, 2020
PubMed

Insights

The mammalian target of rapamycin complex 1 (mTORC1) pathway is crucial for controlling cellular responses to stress and viral infections like HIV-1. Targeting mTORC1 shows promise for eradicating HIV-1 by disrupting its life cycle and related diseases.

Area of Science:

  • Cellular Biology
  • Virology
  • Immunology

Background:

  • Mammalian target of rapamycin complex 1 (mTORC1) regulates cell growth, survival, and stress responses.
  • HIV-1 infection significantly impacts and hijacks the mTORC1 pathway.
  • Host cells utilize mTORC1 and autophagy to combat viral replication and transmission.

Purpose of the Study:

  • To review the multifaceted role of the mTORC1 pathway throughout the HIV-1 life cycle.
  • To elucidate mTORC1's involvement in HIV-1 latency and associated diseases.
  • To explore emerging therapeutic strategies targeting mTORC1 for HIV-1 eradication.

Main Methods:

  • Comprehensive literature review of existing research on mTORC1 and HIV-1.
  • Analysis of molecular mechanisms underlying mTORC1 pathway interference by HIV-1.
  • Synthesis of current findings on mTORC1 targeting for HIV-1 treatment.

Main Results:

  • mTORC1 pathway is manipulated by HIV-1 at all infection stages.
  • Host cell defense against HIV-1 relies on mTORC1 and autophagy.
  • Targeting mTORC1 presents a potential therapeutic avenue for HIV-1.

Conclusions:

  • The mTORC1 pathway is a central player in HIV-1 pathogenesis and host response.
  • Understanding mTORC1 dynamics is key to developing novel HIV-1 eradication strategies.
  • Therapeutic targeting of mTORC1 offers a promising direction for future HIV-1 treatments.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K